ITLN
Aviation

MIAL becomes the first Indian airport to receive CEIV Pharma

April 22, 2019: The Mumbai International Airport Limited (MIAL), a joint venture between Airports Authority of India (AAI), and a GVK-led consortium has become the first Indian airport and third in Asia to achieve the International Air Transport Association (IATA) Center of Excellence for Independent Validators (CEIV) Pharma certification.

MIAL has initiated the certification process in a community approach manner together with its air cargo supply chain partners.
X
MIAL has initiated the certification process in a community approach manner together with its air cargo supply chain partners.

April 22, 2019: The Mumbai International Airport Limited (MIAL), a joint venture between Airports Authority of India (AAI), and a GVK-led consortium has become the first Indian airport and third in Asia to achieve the International Air Transport Association (IATA) Center of Excellence for Independent Validators (CEIV) Pharma certification.

MIAL has achieved this quality milestone for pharma logistics following successful completion of training courses, on-site assessment, and complex validation processes. Acknowledging the importance of this initiative, MIAL has initiated the certification process in a community approach manner together with its air cargo supply chain partners.

The IATA CEIV Pharma certification is introduced to prevent temperature excursions of pharma products during air transport with the key objective of patient safety and reduction of losses attributed to logistical issues. It aims to improve the handling of pharmaceutical cargo by complying with existing national and international regulations. The authorisation ensures seamless handling, adequately equipped facilities, safety & security, standardisation and transparency in the pharma supply chain across the air transport.

The GVK-led consortium consists of Airports Company South Africa (ACSA) and Bidvest which holds 74 percent and AAI by 26 percent.

Next Story
Share it